PubRank

B E Kemp

Author PubWeight™ 233.95‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Protein kinase phosphorylation site sequences and consensus specificity motifs: tabulations. Methods Enzymol 1991 6.72
2 Protein kinase C contains a pseudosubstrate prototope in its regulatory domain. Science 1987 5.23
3 Role of multiple basic residues in determining the substrate specificity of cyclic AMP-dependent protein kinase. J Biol Chem 1977 4.87
4 A parathyroid hormone-related protein implicated in malignant hypercalcemia: cloning and expression. Science 1987 4.09
5 AMP-activated protein kinase phosphorylation of endothelial NO synthase. FEBS Lett 1999 3.63
6 Functional domains of the alpha1 catalytic subunit of the AMP-activated protein kinase. J Biol Chem 1998 3.53
7 A potent synthetic peptide inhibitor of the cAMP-dependent protein kinase. J Biol Chem 1986 3.49
8 Mammalian AMP-activated protein kinase subfamily. J Biol Chem 1996 3.47
9 Phosphorylation of Thr(495) regulates Ca(2+)/calmodulin-dependent endothelial nitric oxide synthase activity. Circ Res 2001 3.18
10 Parathyroid hormone-related protein purified from a human lung cancer cell line. Proc Natl Acad Sci U S A 1987 3.06
11 Structural basis of autoregulation of phenylalanine hydroxylase. Nat Struct Biol 1999 2.67
12 Mammalian AMP-activated protein kinase shares structural and functional homology with the catalytic domain of yeast Snf1 protein kinase. J Biol Chem 1994 2.57
13 Coordinated control of endothelial nitric-oxide synthase phosphorylation by protein kinase C and the cAMP-dependent protein kinase. J Biol Chem 2001 2.56
14 Contraction-induced changes in acetyl-CoA carboxylase and 5'-AMP-activated kinase in skeletal muscle. J Biol Chem 1997 2.54
15 AMP-activated protein kinase is highly expressed in neurons in the developing rat brain and promotes neuronal survival following glucose deprivation. J Mol Neurosci 2001 2.51
16 The Akt kinase signals directly to endothelial nitric oxide synthase. Curr Biol 1999 2.42
17 Isolation of phosphorylated peptides and proteins on ion exchange papers. Anal Biochem 1978 2.33
18 Crystal structure of human T cell leukemia virus type 1 gp21 ectodomain crystallized as a maltose-binding protein chimera reveals structural evolution of retroviral transmembrane proteins. Proc Natl Acad Sci U S A 1999 2.32
19 Insulin activation of acetyl-CoA carboxylase accompanied by inhibition of the 5'-AMP-activated protein kinase. J Biol Chem 1992 2.22
20 Components of a calmodulin-dependent protein kinase cascade. Molecular cloning, functional characterization and cellular localization of Ca2+/calmodulin-dependent protein kinase kinase beta. J Biol Chem 1998 2.10
21 Reciprocal phosphorylation and regulation of endothelial nitric-oxide synthase in response to bradykinin stimulation. J Biol Chem 2001 2.04
22 Cellular distribution and developmental expression of AMP-activated protein kinase isoforms in mouse central nervous system. J Neurochem 1999 1.99
23 Regulation of 5'-AMP-activated protein kinase activity by the noncatalytic beta and gamma subunits. J Biol Chem 1996 1.93
24 Inhibition of cystic fibrosis transmembrane conductance regulator by novel interaction with the metabolic sensor AMP-activated protein kinase. J Clin Invest 2000 1.86
25 Ca2+/S100 regulation of giant protein kinases. Nature 1996 1.86
26 The influence of basic residues on the substrate specificity of protein kinase C. J Biol Chem 1987 1.80
27 Substrate specificity of a multifunctional calmodulin-dependent protein kinase. J Biol Chem 1985 1.80
28 Synthetic hexapeptide substrates and inhibitors of 3':5'-cyclic AMP-dependent protein kinase. Proc Natl Acad Sci U S A 1976 1.75
29 The calmodulin binding domain of chicken smooth muscle myosin light chain kinase contains a pseudosubstrate sequence. J Biol Chem 1987 1.72
30 Post-translational modifications of the beta-1 subunit of AMP-activated protein kinase affect enzyme activity and cellular localization. Biochem J 2001 1.69
31 Substrate specificity of the cyclic AMP-dependent protein kinase. Proc Natl Acad Sci U S A 1975 1.68
32 An activating mutation in the gamma1 subunit of the AMP-activated protein kinase. FEBS Lett 2001 1.65
33 Regulatory and structural motifs of chicken gizzard myosin light chain kinase. Proc Natl Acad Sci U S A 1990 1.62
34 Calcium/calmodulin-dependent protein kinase II. Characterization of distinct calmodulin binding and inhibitory domains. J Biol Chem 1988 1.60
35 Insights into autoregulation from the crystal structure of twitchin kinase. Nature 1994 1.55
36 Mammalian 5'-AMP-activated protein kinase non-catalytic subunits are homologs of proteins that interact with yeast Snf1 protein kinase. J Biol Chem 1994 1.50
37 Posttranslational modifications of the 5'-AMP-activated protein kinase beta1 subunit. J Biol Chem 1997 1.49
38 Functional analysis of a complementary DNA for the 50-kilodalton subunit of calmodulin kinase II. Science 1987 1.48
39 Mutagenesis of the pseudosubstrate site of protein kinase C leads to activation. Eur J Biochem 1990 1.47
40 Crystallization of a trimeric human T cell leukemia virus type 1 gp21 ectodomain fragment as a chimera with maltose-binding protein. Protein Sci 1998 1.45
41 AMPK signaling in contracting human skeletal muscle: acetyl-CoA carboxylase and NO synthase phosphorylation. Am J Physiol Endocrinol Metab 2000 1.41
42 Proteolysis of smooth muscle myosin light chain kinase. Formation of inactive and calmodulin-independent fragments. J Biol Chem 1987 1.39
43 Non-catalytic beta- and gamma-subunit isoforms of the 5'-AMP-activated protein kinase. J Biol Chem 1996 1.37
44 Active site-directed protein regulation. Nature 1999 1.37
45 Human immunodeficiency virus type 1 envelope glycoprotein oligomerization requires the gp41 amphipathic alpha-helical/leucine zipper-like sequence. J Virol 1997 1.31
46 Structural basis of the intrasteric regulation of myosin light chain kinases. Science 1992 1.31
47 Phosphorylation site sequence of smooth muscle myosin light chain (Mr = 20 000). FEBS Lett 1984 1.31
48 Effects of modulators of myosin light-chain kinase activity in single smooth muscle cells. Nature 1989 1.30
49 Functional properties of hormonally responsive cultured normal and malignant rat osteoblastic cells. Endocrinology 1981 1.29
50 Parathyroid hormone-related protein: immunohistochemical localization in cancers and in normal skin. J Bone Miner Res 1989 1.28
51 Design and use of peptide substrates for protein kinases. Methods Enzymol 1991 1.28
52 AMP-activated protein kinase isoenzyme family: subunit structure and chromosomal location. FEBS Lett 1997 1.28
53 Human factor H-related protein 5 (FHR-5). A new complement-associated protein. J Biol Chem 2000 1.26
54 Role of basic residues in the phosphorylation of synthetic peptides by myosin light chain kinase. Proc Natl Acad Sci U S A 1983 1.26
55 Stimulation of AMP-activated protein kinase (AMPK) is associated with enhancement of Glut1-mediated glucose transport. Arch Biochem Biophys 2000 1.25
56 Giant protein kinases: domain interactions and structural basis of autoregulation. EMBO J 1996 1.24
57 Substrate specificities for yeast and mammalian cAMP-dependent protein kinases are similar but not identical. J Biol Chem 1991 1.24
58 Autoregulation of enzymes by pseudosubstrate prototopes: myosin light chain kinase. Science 1988 1.23
59 Proteomic-based identification of haptoglobin-1 precursor as a novel circulating biomarker of ovarian cancer. Br J Cancer 2004 1.23
60 Identification of substrate specificity determinants for the cell cycle-regulated NIMA protein kinase. J Biol Chem 1994 1.21
61 Determinants of human immunodeficiency virus type 1 envelope glycoprotein oligomeric structure. J Virol 1995 1.19
62 Isoform-specific purification and substrate specificity of the 5'-AMP-activated protein kinase. J Biol Chem 1996 1.19
63 Expression of the AMP-activated protein kinase beta1 and beta2 subunits in skeletal muscle. FEBS Lett 1999 1.19
64 The myosin-I-binding protein Acan125 binds the SH3 domain and belongs to the superfamily of leucine-rich repeat proteins. Proc Natl Acad Sci U S A 1997 1.17
65 Differential and common recognition of the catalytic sites of the cGMP-dependent and cAMP-dependent protein kinases by inhibitory peptides derived from the heat-stable inhibitor protein. J Biol Chem 1986 1.16
66 Endothelium and the vasodilator action of rat calcitonin gene-related peptide (CGRP). Br J Pharmacol 1987 1.14
67 Cellular stress regulates the nucleocytoplasmic distribution of the protein-tyrosine phosphatase TCPTP. J Biol Chem 2001 1.13
68 ADR1c mutations enhance the ability of ADR1 to activate transcription by a mechanism that is independent of effects on cyclic AMP-dependent protein kinase phosphorylation of Ser-230. Mol Cell Biol 1992 1.13
69 The protein-tyrosine phosphatase TCPTP regulates epidermal growth factor receptor-mediated and phosphatidylinositol 3-kinase-dependent signaling. J Biol Chem 1999 1.13
70 Examination of 'lipotoxicity' in skeletal muscle of high-fat fed and ob/ob mice. J Physiol 2009 1.13
71 Pseudosubstrate-based peptide inhibitors. Methods Enzymol 1991 1.11
72 Progressive increase in human skeletal muscle AMPKalpha2 activity and ACC phosphorylation during exercise. Am J Physiol Endocrinol Metab 2002 1.10
73 Functional implications of the human T-lymphotropic virus type 1 transmembrane glycoprotein helical hairpin structure. J Virol 2000 1.08
74 Catalytic subunits of the porcine and rat 5'-AMP-activated protein kinase are members of the SNF1 protein kinase family. Biochim Biophys Acta 1995 1.07
75 Reduced AMP-activated protein kinase activity in mouse skeletal muscle does not exacerbate the development of insulin resistance with obesity. Diabetologia 2009 1.06
76 Regulation of intrasteric inhibition of the multifunctional calcium/calmodulin-dependent protein kinase. Proc Natl Acad Sci U S A 1992 1.05
77 Structure and function of AMP-activated protein kinase. Acta Physiol (Oxf) 2009 1.04
78 Circular dichroic evidence for an ordered sequence of ligand/binding site interactions in the catalytic reaction of the cAMP-dependent protein kinase. Biochemistry 1985 1.04
79 Two apparent molecular weight forms of human and monkey phenylalanine hydroxylase are due to phosphorylation. J Biol Chem 1984 1.04
80 A synthetic peptide analog of the putative substrate-binding motif activates protein kinase C. FEBS Lett 1989 1.03
81 Phosphorylation of myelin basic protein by an adenosine 3':5'-cyclic monophosphate-dependent protein kinase. Biochem J 1973 1.03
82 Prevention of albuminuria by aminoguanidine or ramipril in streptozotocin-induced diabetic rats is associated with the normalization of glomerular protein kinase C. Diabetes 2000 1.03
83 AMP-Activated protein kinase is activated by the stimulations of G(q)-coupled receptors. Biochem Biophys Res Commun 2000 1.02
84 Effect of exercise intensity and hypoxia on skeletal muscle AMPK signaling and substrate metabolism in humans. Am J Physiol Endocrinol Metab 2005 1.02
85 Antibody epitopes sensitive to the state of human immunodeficiency virus type 1 gp41 oligomerization map to a putative alpha-helical region. AIDS Res Hum Retroviruses 1992 1.01
86 Regulation and crystallization of phosphorylated and dephosphorylated forms of truncated dimeric phenylalanine hydroxylase. Protein Sci 1997 1.00
87 Peptide inhibitors of cAMP-dependent protein kinase. Methods Enzymol 1988 1.00
88 Multiple Ca(2+)-calmodulin-dependent protein kinase kinases from rat brain. Purification, regulation by Ca(2+)-calmodulin, and partial amino acid sequence. J Biol Chem 1996 0.99
89 Substrate specificity of phospholipid/Ca2+-dependent protein kinase as probed with synthetic peptide fragments of the bovine myelin basic protein. J Biol Chem 1985 0.99
90 Mapping of calmodulin-binding domain of Ca2+/calmodulin-dependent protein kinase II from rat brain. Biochem Biophys Res Commun 1988 0.98
91 Use of a conserved immunodominant epitope of HIV surface glycoprotein gp41 in the detection of early antibodies. AIDS 1990 0.96
92 Human immunodeficiency virus type 1 and 2 envelope glycoproteins oligomerize through conserved sequences. J Virol 1997 0.95
93 In vivo phosphorylation of a synthetic peptide substrate of cyclic AMP-dependent protein kinase. Proc Natl Acad Sci U S A 1978 0.95
94 Phosphorylation of selected serine and threonine residues in myelin basic protein by endogenous and exogenous protein kinases. Nature 1974 0.95
95 Analysis of budding yeast kinases controlled by DNA damage. Methods Enzymol 1997 0.95
96 Intensified exercise training does not alter AMPK signaling in human skeletal muscle. Am J Physiol Endocrinol Metab 2003 0.95
97 Phosphorylation of ribosomal protein S6 and a peptide analogue of S6 by a protease-activated kinase isolated from rat liver. FEBS Lett 1984 0.95
98 Myosin light chain kinase structure function analysis using bacterial expression. J Biol Chem 1989 0.94
99 A monoclonal antibody to the phosphorylated form of phenylalanine hydroxylase. Definition of the phosphopeptide epitope. Biochem J 1987 0.94
100 Spatial requirements for location of basic residues in peptide substrates for smooth muscle myosin light chain kinase. J Biol Chem 1985 0.94
101 Evidence that the pertussis toxin-sensitive trimeric GTP-binding protein Gi2 is required for agonist- and store-activated Ca2+ inflow in hepatocytes. J Biol Chem 1995 0.93
102 Selective hormonal activation of cyclic AMP-dependent protein kinase isoenzymes in normal and malignant osteoblasts. J Biol Chem 1982 0.93
103 Localization of cofactor binding sites with monoclonal anti-idiotype antibodies: phenylalanine hydroxylase. Proc Natl Acad Sci U S A 1991 0.93
104 Hepatic 5'-AMP-activated protein kinase: zonal distribution and relationship to acetyl-CoA carboxylase activity in varying nutritional states. Arch Biochem Biophys 1994 0.91
105 FHA domain boundaries of the dun1p and rad53p cell cycle checkpoint kinases. FEBS Lett 2000 0.91
106 Phosphorylation of acyl and dansyl derivatives of the peptide Leu-Arg-Arg-Ala-Ser-Leu-Gly by the cAMP-dependent protein kinase. J Biol Chem 1980 0.91
107 Further studies on the structure of the glycogen-bound form of protein phosphatase-1 from rabbit skeletal muscle. Eur J Biochem 1987 0.89
108 Characteristics of selective activation of cyclic AMP-dependent protein kinase isoenzymes by calcitonin and prostaglandin E2 in human breast cancer cells. Biochem J 1984 0.89
109 A potent inhibitor of osteoclastic bone resorption within a highly conserved pentapeptide region of parathyroid hormone-related protein; PTHrP[107-111]. Endocrinology 1991 0.89
110 Phosphorylation of a synthetic gastrin peptide by the tyrosine kinase of A431 cell membranes. Biochem Biophys Res Commun 1982 0.89
111 Phosphorylation at the cyclin-dependent kinases site (Thr85) of parathyroid hormone-related protein negatively regulates its nuclear localization. J Biol Chem 1999 0.89
112 Arg21 is the preferred kexin cleavage site in parathyroid-hormone-related protein. Eur J Biochem 1995 0.88
113 Evidence for a second phosphorylation site on eIF-2 alpha from rabbit reticulocytes. FEBS Lett 1987 0.88
114 Peptide specificity determinants at P-7 and P-6 enhance the catalytic efficiency of Ca2+/calmodulin-dependent protein kinase I in the absence of activation loop phosphorylation. J Biol Chem 1999 0.88
115 Phosphorylation of synthetic peptides by skeletal muscle myosin light chain kinases. J Biol Chem 1986 0.88
116 Activation of adenosine 3',5'-monophosphate-dependent protein kinase in normal and malignant bone cells by parathyroid hormone, prostaglandin E2, and prostacyclin. Endocrinology 1981 0.88
117 Atrial natriuretic peptide-dependent phosphorylation of smooth muscle cell particulate fraction proteins is mediated by cGMP-dependent protein kinase. J Biol Chem 1989 0.88
118 Substrate specificity and inhibitor sensitivity of Ca2+/S100-dependent twitchin kinases. Eur J Biochem 1996 0.88
119 Smooth muscle myosin kinase requires residues on the COOH-terminal side of the phosphorylation site. Peptide inhibitors. J Biol Chem 1986 0.88
120 Histone phosphatase and cyclic nucleotide-stimulated protein kinase from human lymphocytes. Biochem J 1972 0.87
121 Malonyl-CoA decarboxylase is not a substrate of AMP-activated protein kinase in rat fast-twitch skeletal muscle or an islet cell line. Arch Biochem Biophys 2001 0.87
122 Phosphorylation of synthetic peptide analogs of rabbit cardiac troponin inhibitory subunit by the cyclic AMP-dependent protein kinase. J Biol Chem 1979 0.87
123 Solution structure of parathyroid hormone related protein (residues 1-34) containing an Ala substituted for an Ile in position 15 (PTHrP[Ala15]-(1-34)). J Biol Chem 1997 0.86
124 A carboxyl-terminal peptide from the parathyroid hormone-related protein inhibits bone resorption by osteoclasts. Endocrinology 1991 0.86
125 Interaction of the recombinant S100A1 protein with twitchin kinase, and comparison with other Ca2+-binding proteins. Eur J Biochem 1997 0.86
126 Heterogeneous effects of exogenous IL-2 on HIV-specific cell-mediated immunity (CMI). Clin Exp Immunol 1992 0.86
127 Differential attenuation of AMPK activation during acute exercise following exercise training or AICAR treatment. J Appl Physiol (1985) 2008 0.86
128 Multiple protein kinases from human lymphocytes. Identification enzymes phosphorylating exogenous histon and casein. Biochem J 1975 0.86
129 Comparison of the anabolic effects of synthetic parathyroid hormone-related protein (PTHrP) 1-34 and PTH 1-34 on bone in rats. Endocrinology 1989 0.85
130 Protein kinase activity in commercially available crystalline yeast alcohol dehydrogenase. Biochem J 1973 0.85
131 Expression of parathyroid hormone related protein in normal skin and in tumours of skin and skin appendages. J Pathol 1989 0.85
132 Intrasteric regulation of protein kinases. Adv Second Messenger Phosphoprotein Res 1997 0.84
133 Definition of an immunodominant T cell epitope contained in the envelope gp41 sequence of HIV-1. Clin Exp Immunol 1992 0.84
134 Calcitonin receptors of human osteoclastoma. Horm Metab Res 1987 0.84
135 Protein kinase C pseudosubstrate prototope: structure-function relationships. Cell Signal 1990 0.83
136 NMR solution structure of human parathyroid hormone(1-34). Biochemistry 1993 0.83
137 A rapid whole-blood immunoassay system. Med J Aust 1990 0.83
138 Adrenergic control of the cyclic AMP-dependent protein kinase and pyruvate kinase in isolated hepatocytes. Application of a synthetic peptide substrate for measuring protein kinase activity. J Biol Chem 1978 0.83
139 Human monoclonal antibodies to HIV-1: cross-reactions with gag and env products. Clin Exp Immunol 1989 0.83
140 Evolutionary conservation of the membrane fusion machine. IUBMB Life 1999 0.83
141 Intrasteric regulation of myosin light chain kinase: the pseudosubstrate prototope binds to the active site. Mol Endocrinol 1992 0.83
142 Phosphorylation of a synthetic heptadecapeptide by smooth muscle myosin light chain kinase. J Biol Chem 1982 0.82
143 Protein kinase CK2: biphasic kinetics with peptide substrates. Arch Biochem Biophys 1996 0.82
144 Myosin light chain kinase binding to plastic. FEBS Lett 1982 0.82
145 Evidence that a low-molecular-mass GTP-binding protein is required for store-activated Ca2+ inflow in hepatocytes. Biochem J 1997 0.82
146 Proteolytic cleavage sites in smooth muscle myosin-light-chain kinase and their relation to structural and regulatory domains. Eur J Biochem 1991 0.82
147 Nonmuscle myosin phosphorylation sites for calcium-dependent and calcium-independent protein kinases. Biochem Biophys Res Commun 1986 0.82
148 Rapid whole blood assay for HIV-1 seropositivity using an Fab-peptide conjugate. J Immunol Methods 1991 0.82
149 A cardiolipin-activated protein kinase from rat liver structurally distinct from the protein kinases C. J Biol Chem 1994 0.82
150 Regulation of membrane-associated tyrosine phosphatases in UMR 106.06 osteoblast-like cells. Biochem J 1995 0.82
151 Activity ratio measurements reflect intracellular activation of adenosine 3',5'-monophosphate-dependent protein kinase in osteoblasts. Endocrinology 1982 0.82
152 NMR study of a 34-residue N-terminal fragment of the parathyroid-hormone-related protein secreted during humoral hypercalcemia of malignancy. Eur J Biochem 1989 0.81
153 Recognition of envelope and tat protein synthetic peptide analogs by HIV positive sera or plasma. FEBS Lett 1988 0.81
154 Synapsins as major neuronal Ca2+/S100A1-interacting proteins. Biochem J 1999 0.81
155 Human placental calcitonin receptors. Biochem J 1988 0.80
156 Humoral hypercalcemia of malignancy: involvement of a novel hormone. Aust N Z J Med 1988 0.80
157 Synthetic peptide substrates for the membrane tyrosine protein kinase stimulated by epidermal growth factor. Eur J Biochem 1984 0.80
158 Phosphorylation of hydroxyproline in a synthetic peptide catalyzed by cyclic AMP-dependent protein kinase. J Biol Chem 1979 0.80
159 NMR of a synthetic peptide spanning the triphosphate binding site of adenosine 5'-triphosphate in actin. Biochemistry 1987 0.78
160 Relaxin. Vitam Horm 1984 0.78
161 Aminoguanidine and ramipril prevent diabetes-induced increases in protein kinase C activity in glomeruli, retina and mesenteric artery. Clin Sci (Lond) 2001 0.78
162 Structure study of osteostatin PTHrP[Thr107](107-139). Biochim Biophys Acta 1999 0.78
163 The smooth muscle 132 kDa cyclic GMP-dependent protein kinase substrate is not myosin light chain kinase or caldesmon. Biochem J 1990 0.78
164 Chicken smooth muscle myosin light chain kinase is acetylated on its NH2-terminal methionine. Mol Cell Biochem 1993 0.78
165 N-terminal residues 105-117 of HIV-1 gp120 are not involved in CD4 binding. AIDS Res Hum Retroviruses 1991 0.77
166 Kinetics of the autologous red cell agglutination test. J Immunol Methods 1993 0.77
167 Comparison of substrate specificity of myosin kinase and cyclic AMP-dependent protein kinase. Biochim Biophys Acta 1984 0.77
168 Hydroxyamino acid specificity of smooth muscle myosin light chain kinase. Arch Biochem Biophys 1988 0.77
169 Synthetic peptides representing sequences within gp41 of HIV as immunogens for murine T- and B-cell responses. Arch Virol 1995 0.77
170 Synthetic myelin basic protein peptide analogs are specific inhibitors of phospholipid/calcium-dependent protein kinase (protein kinase C). Biochem Biophys Res Commun 1986 0.77
171 Regulation of smooth muscle myosin light chain kinase by calmodulin. Adv Exp Med Biol 1991 0.77
172 Phosphorylation of phospholamban in aortic smooth muscle cells and heart by calcium/calmodulin-dependent protein kinase II. Cell Signal 1994 0.77
173 Histone 4 phosphotransferase activities in proliferating lymphocytes. Partial purification and characterization of an enzyme specific for Ser-47. J Biol Chem 1977 0.77
174 Crystallization and preliminary X-ray analysis of the auto-inhibited twitchin kinase. J Mol Biol 1994 0.76
175 Muscle phosphorylase kinase is not a substrate of AMP-activated protein kinase. Biol Chem 2000 0.76
176 Biologically active, derivatizable salmon calcitonin analog: design, synthesis, and applications. Endocrinology 1988 0.76
177 Chemical modification of lysine and arginine residues in the myosin regulatory light chain inhibits phosphorylation. Biochim Biophys Acta 1986 0.76
178 Comparison of the effects of amino-terminal synthetic parathyroid hormone-related peptide (PTHrP) of malignancy and parathyroid hormone on resorption of cultured fetal rat long bones. Calcif Tissue Int 1990 0.76
179 Solubilization of functional calcitonin receptors. Biochem J 1988 0.76
180 Mutation-directed chemical cross-linking of human immunodeficiency virus type 1 gp41 oligomers. J Virol 1998 0.76
181 Reversible calcitonin binding to solubilized sheep brain binding sites. Biochem J 1991 0.76
182 Stabilized NMR structure of the hypercalcemia of malignancy peptide PTHrP[Ala-26](1-34)amide. Biochim Biophys Acta 1994 0.75
183 Evidence that the PTH receptor binding site on PTHrP(1-34) can hinge at Arg19/Arg20. Biochem Biophys Res Commun 1996 0.75
184 Rapid characterization of protein epitopes recognized by monoclonal antibodies using direct probing on thin-layer and paper chromatograms. J Immunol Methods 1987 0.75
185 Myosin light chain kinase autoregulatory pseudosubstrate prototope. Pept Res 1992 0.75
186 Active tyrosine phosphatase in immunoprecipitates of multiple isoforms of Ly-5. Cell Signal 1990 0.75
187 A rapid test for endotoxin in whole blood. Prog Clin Biol Res 1995 0.75
188 Casein kinase II beta-subunit inhibits the activity of the catalytic alpha-subunit in the absence of salt. Biochim Biophys Acta 1993 0.75
189 Simplified conjugation chemistry for coupling peptides to F(ab') fragments: autologous red cell agglutination assay for HIV-1 antibodies. J Immunol Methods 1994 0.75
190 Determinants of multi-site phosphorylation of peptide analogues of ribosomal protein S6 by novel protease-activated protein kinases. Pept Res 1992 0.75
191 CD8+ T-cells from HIV-infected patients can either augment or abrogate HIV-specific lymphoproliferation. Clin Immunol Immunopathol 1992 0.75
192 Effects of hemin on rat liver cyclic AMP-dependent protein kinases in cell extracts and intact hepatocytes. Biochim Biophys Acta 1985 0.75
193 A monoclonal antibody raised against an undecapeptide sequence from human transforming growth factor alpha recognizes a hexapeptide epitope in mitotic centrosomes. Lab Invest 1990 0.75
194 Insert regions in domain X of the casein kinase II catalytic subunit. Eur J Biochem 1995 0.75
195 Autologous red cell agglutination test for antibodies to feline immunodeficiency virus. Vet Immunol Immunopathol 1994 0.75
196 Changes in the specific activity of (gamma-32P)ATP during protein kinase assays of crude lymphocyte extracts. Biochim Biophys Acta 1974 0.75
197 Pseudosubstrate flexibility in chicken smooth muscle myosin light chain kinase. Biochem Biophys Res Commun 1996 0.75
198 The effect of somatostatin on the activation of adenosine 3',5'-monophosphate-dependent protein kinase in isolated rat islets of Langerhans. Endocrinology 1980 0.75
199 FTIR spectroscopy study of PTHrP(1-34) involved in humoral hypercalcaemia of malignancy. Biochim Biophys Acta 1993 0.75
200 NMR solution structure of the [Ala26]parathyroid-hormone-related protein(1-34) expressed in humoral hypercalcemia of malignancy. Eur J Biochem 1993 0.75
201 Role of the pseudosubstrate sequence in smooth muscle myosin light chain kinase thermal stability. J Biol Chem 1993 0.75
202 Inhibition of phenylephrine-stimulated gluconeogenesis by chlorpromazine is mediated by alpha-adrenergic receptors. FEBS Lett 1981 0.75
203 Structure of the pseudosubstrate recognition site of chicken smooth muscle myosin light chain kinase. Biochim Biophys Acta 1996 0.75